Haydn Till
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Haydn Till has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Doug Shelton
Child Development Service Gold Coast Hospital Gold Coast Queensland Australia
2 shared publicationsAlison Crichton
Victorian Fetal Alcohol Service Monash Children's Hospital Clayton Victoria Australia
1 shared publicationAmy Finlay‐Jones
Telethon Kids Institute Nedlands Western Australia Australia
1 shared publicationBronwyn M. Theroux
School of Applied Psychology Griffith University Queensland Australia
1 shared publication- Bruce D. Watt
Bond University
1 shared publication - Carmela Pestell
The University of Western Australia
1 shared publication
Latest Publications
- 22 October 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (1) , 16-22
A Pilot Randomised Controlled Trial of Sublingual Melatonin for Sleep Onset Insomnia in Children With Foetal Alcohol Spectrum Disorder ( FASD )
Aim: Children with foetal alcohol spectrum disorder (FASD) present with significant sleep disturbance. This pilot trial aimed to examine the feasibility of conducting a larger randomised controlled trial (RCT) in this population and the potential effectiveness of melatonin to treat onset insomnia. Methods: Children with sleep onset delay and a designation of ‘at risk’ of FASD or a diagnosis of FASD were recruited to a 10‐week, double‐blind, placebo‐controlled, crossover study of melatonin. Sleep outcomes were assessed using actigraphy. The child sleep habit questionnaire (CSHQ) and measures of executive functioning and carer stress were completed at baseline and after each treatment phase. Results: Fifty‐nine children were assessed for eligibility, 18 were ineligible as they were taking sleep medication, and eight children entered the trial. Four received melatonin for 3 weeks followed by placebo for 3 weeks (arm A) and four received placebo followed by melatonin (arm B). Processes involving data collection and retention were acceptable. However, significant issues regarding recruitment were found. Quantitative measures were appropriate with significant reductions in sleep onset latency ( n = 6) in the melatonin condition relative to the placebo condition ( p = 0.003), and bedtime resistance ( n = 8) according to the CSHQ ( p = 0.004). No serious adverse events were reported. Conclusions: A randomised crossover design was feasible in this population; however, recruitment should be conducted across multiple sites. Melatonin is potentially effective at reducing sleep onset latency and behaviour difficulties at bedtime in children with or ‘at risk’ of FASD. Trial Registration: Australian New Zealand Clinical Trials Registry (12619001360101).
- 22 October 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 62 (1) , 16-22
A Pilot Randomised Controlled Trial of Sublingual Melatonin for Sleep Onset Insomnia in Children With Foetal Alcohol Spectrum Disorder ( FASD )
Aim: Children with foetal alcohol spectrum disorder (FASD) present with significant sleep disturbance. This pilot trial aimed to examine the feasibility of conducting a larger randomised controlled trial (RCT) in this population and the potential effectiveness of melatonin to treat onset insomnia. Methods: Children with sleep onset delay and a designation of ‘at risk’ of FASD or a diagnosis of FASD were recruited to a 10‐week, double‐blind, placebo‐controlled, crossover study of melatonin. Sleep outcomes were assessed using actigraphy. The child sleep habit questionnaire (CSHQ) and measures of executive functioning and carer stress were completed at baseline and after each treatment phase. Results: Fifty‐nine children were assessed for eligibility, 18 were ineligible as they were taking sleep medication, and eight children entered the trial. Four received melatonin for 3 weeks followed by placebo for 3 weeks (arm A) and four received placebo followed by melatonin (arm B). Processes involving data collection and retention were acceptable. However, significant issues regarding recruitment were found. Quantitative measures were appropriate with significant reductions in sleep onset latency ( n = 6) in the melatonin condition relative to the placebo condition ( p = 0.003), and bedtime resistance ( n = 8) according to the CSHQ ( p = 0.004). No serious adverse events were reported. Conclusions: A randomised crossover design was feasible in this population; however, recruitment should be conducted across multiple sites. Melatonin is potentially effective at reducing sleep onset latency and behaviour difficulties at bedtime in children with or ‘at risk’ of FASD. Trial Registration: Australian New Zealand Clinical Trials Registry (12619001360101).
- Open Access
- 3 February 2025
- Published by SAGE Publications in Journal of Psychoeducational Assessment
- Vol. 43 (3) , 255-272
Multidimensional Scaling of the Wechsler Intelligence Scales for Children in a Clinical Sample Assessed for Fetal Alcohol Spectrum Disorder (FASD)
Fetal Alcohol Spectrum Disorder (FASD) is a significant public health concern arising from prenatal alcohol exposure. This study examines the clinical utility of Wechsler intelligence tests in assessing cognition in 108 children with confirmed prenatal alcohol exposure. Data were analysed using multidimensional scaling and Guttman’s Structural Model of Intelligence, with a view to assessing the application of the Wechsler Intelligence Scale for Children 4th Edition (WISC-IV) and 5th Edition (WISC-V) in characterising cognitive ability for this clinical population. WISC-IV and WISC-V subtests exhibited distinct clustering patterns within the sample compared to normative populations. Subtests appeared to cluster based on response modality, aligning with Guttman’s Structural Model of Intelligence. The findings demonstrate an alternative interpretation approach for intelligence tests in children with prenatal alcohol exposure, which may complement existing FASD diagnostic frameworks. The clustering patterns underscore the importance of considering response modality in understanding cognitive abilities.
- 3 February 2025
- Published by SAGE Publications in Journal of Psychoeducational Assessment
- Vol. 43 (3) , 255-272
Open AccessMultidimensional Scaling of the Wechsler Intelligence Scales for Children in a Clinical Sample Assessed for Fetal Alcohol Spectrum Disorder (FASD)
Fetal Alcohol Spectrum Disorder (FASD) is a significant public health concern arising from prenatal alcohol exposure. This study examines the clinical utility of Wechsler intelligence tests in assessing cognition in 108 children with confirmed prenatal alcohol exposure. Data were analysed using multidimensional scaling and Guttman’s Structural Model of Intelligence, with a view to assessing the application of the Wechsler Intelligence Scale for Children 4th Edition (WISC-IV) and 5th Edition (WISC-V) in characterising cognitive ability for this clinical population. WISC-IV and WISC-V subtests exhibited distinct clustering patterns within the sample compared to normative populations. Subtests appeared to cluster based on response modality, aligning with Guttman’s Structural Model of Intelligence. The findings demonstrate an alternative interpretation approach for intelligence tests in children with prenatal alcohol exposure, which may complement existing FASD diagnostic frameworks. The clustering patterns underscore the importance of considering response modality in understanding cognitive abilities.
- Open Access
- 12 May 2023
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 47 (7) , 1209-1223
Lived experiences of the diagnostic assessment process for fetal alcohol spectrum disorder: A systematic review of qualitative evidence
Early assessment and diagnosis of FASD are crucial in providing therapeutic interventions that aim to enhance meaningful participation and quality of life for individuals and their families, while reducing psychosocial difficulties that may arise during adolescence and adulthood. Individuals with lived experience of FASD have expertise based on their own lives and family needs. Their insights into the assessment and diagnostic process are valuable for improving service delivery and informing the provision of meaningful, person‐ and family‐centered care. To date, reviews have focused broadly on the experiences of living with FASD. The aim of this systematic review is to synthesize qualitative evidence on the lived experiences of the diagnostic assessment process for FASD. Six electronic databases, including PubMed, the Cochrane Library, CINAH, EMBASE, PsycINFO, and Web of Science Core Collection were searched from inception until February 2021, and updated in December 2022. A manual search of reference lists of included studies identified additional studies for inclusion. The quality of included studies was assessed using the Critical Appraisal Skills Program Checklist for Qualitative Studies. Data from included studies were synthesized using a thematic analysis approach. GRADE‐CERQual was used to assess confidence in the review findings. Ten studies met the selection criteria for inclusion in the review. Thematic analysis identified 10 first‐level themes relating to four over‐arching topics: (1) pre‐assessment concerns and challenges, (2) the diagnostic assessment process, (3) receipt of the diagnosis, and (4) post‐assessment adaptations and needs. GRADE‐CERQual confidence ratings for each of the review themes were moderate to high. The findings from this review have implications for referral pathways, client‐centered assessment processes, and post‐diagnostic recommendations and support.
- 12 May 2023
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 47 (7) , 1209-1223
Open AccessLived experiences of the diagnostic assessment process for fetal alcohol spectrum disorder: A systematic review of qualitative evidence
Early assessment and diagnosis of FASD are crucial in providing therapeutic interventions that aim to enhance meaningful participation and quality of life for individuals and their families, while reducing psychosocial difficulties that may arise during adolescence and adulthood. Individuals with lived experience of FASD have expertise based on their own lives and family needs. Their insights into the assessment and diagnostic process are valuable for improving service delivery and informing the provision of meaningful, person‐ and family‐centered care. To date, reviews have focused broadly on the experiences of living with FASD. The aim of this systematic review is to synthesize qualitative evidence on the lived experiences of the diagnostic assessment process for FASD. Six electronic databases, including PubMed, the Cochrane Library, CINAH, EMBASE, PsycINFO, and Web of Science Core Collection were searched from inception until February 2021, and updated in December 2022. A manual search of reference lists of included studies identified additional studies for inclusion. The quality of included studies was assessed using the Critical Appraisal Skills Program Checklist for Qualitative Studies. Data from included studies were synthesized using a thematic analysis approach. GRADE‐CERQual was used to assess confidence in the review findings. Ten studies met the selection criteria for inclusion in the review. Thematic analysis identified 10 first‐level themes relating to four over‐arching topics: (1) pre‐assessment concerns and challenges, (2) the diagnostic assessment process, (3) receipt of the diagnosis, and (4) post‐assessment adaptations and needs. GRADE‐CERQual confidence ratings for each of the review themes were moderate to high. The findings from this review have implications for referral pathways, client‐centered assessment processes, and post‐diagnostic recommendations and support.